MRI study sharpens local staging picture for canine bone sarcomas: full analysis

A new study in the Journal of Small Animal Practice suggests MRI may deserve a bigger role in local staging for dogs with primary appendicular bone sarcomas. In a prospective series of 20 dogs, investigators found that T2 STIR MRI sequences showed significantly greater intramedullary lesion extension than CT and other MRI sequences, pointing to a possible gap in how far disease spreads within the affected bone when CT is used alone. (pubmed.ncbi.nlm.nih.gov)

The work comes as veterinary teams continue to refine how they stage and plan treatment for canine appendicular bone tumors, especially osteosarcoma, the most common primary bone tumor in dogs. Radiographs remain the first-line tool for identifying aggressive bone lesions, while CT is widely used for staging and surgical planning. Still, prior reviews and consensus guidance have noted that MRI can offer more detailed local anatomic information, particularly when clinicians need to assess tissue involvement or plan limb-sparing procedures. (pmc.ncbi.nlm.nih.gov)

In the new study, dogs with confirmed primary appendicular bone sarcoma were prospectively recruited at a single small animal referral center between June 2023 and October 2024. All dogs had contrast-enhanced CT followed by MRI. Fifteen dogs had osteosarcoma, four had primary bone sarcoma of uncertain origin, and one had hemangiosarcoma. The most common MRI findings were heterogeneous hyperintensity on T2 STIR images, heterogeneous hypointensity on T1- and T2-weighted images, medullary and cortical osteolysis, a peripheral mass, and a long transitional zone. Notably, a suspected skip metastasis was seen on MRI in one dog but not on the corresponding CT. (pubmed.ncbi.nlm.nih.gov)

That last point is clinically interesting because skip lesions and true intramedullary extent can influence how aggressively surgeons approach local control. The paper's authors concluded that MRI findings in these canine tumors were similar to patterns described in people and in prior reports of canine axial osteosarcoma, and they specifically argued that MRI, more precisely T2 STIR imaging, should be included in local staging for appendicular primary bone sarcomas in dogs. Earlier literature has also suggested MRI is especially valuable for accurate local staging of appendicular osteosarcoma, even if it is used less often than CT in routine veterinary practice. (pubmed.ncbi.nlm.nih.gov)

Direct outside commentary on this specific paper appears limited so far, but the findings line up with broader expert thinking in veterinary oncology and imaging. Recent consensus guidance on canine appendicular osteosarcoma says advanced imaging such as CT or MRI can aid precise tumor localization and assessment of local tissue involvement, while Cornell’s oncology resources similarly note that CT or MRI can be particularly helpful when planning involved surgical procedures. In other words, this study doesn't overturn current practice, but it does strengthen the case for MRI in selected referral cases where local staging details matter most. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, the practical takeaway is less about replacing CT across the board and more about knowing when CT may not be enough. If MRI, especially STIR, better captures longitudinal marrow involvement, that could affect candidacy assessments for limb-sparing, surgical margin planning, and conversations with pet parents about expected local control. It may also matter in research settings and specialty oncology workflows where more precise baseline characterization could improve case selection and follow-up. At the same time, current consensus guidance still notes that advanced imaging is not a prerequisite for rational definitive therapy in every dog with appendicular osteosarcoma, so access, cost, anesthesia time, and intended treatment plan will continue to shape uptake. (pubmed.ncbi.nlm.nih.gov)

What to watch: The next question is whether this imaging advantage translates into management changes or better outcomes. Larger multicenter studies could help determine whether MRI-detected disease extent alters surgical margins, limb-sparing success, local recurrence, or survival, and whether MRI should be reserved for selected cases or folded more routinely into appendicular bone sarcoma staging protocols. (pubmed.ncbi.nlm.nih.gov)